FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for bromocriptine mesylate from Sandoz Inc, approving a modification to an existing generic product's labeling/indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

SUPPL AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)